Skip to main content

Closed

XCUR: Exicure, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-98.9%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-8759.0×

Current ratio0.79×

Exicure, Inc.

XCURNASDAQ Capital Market·USD·Closed

Exicure, Inc.

XCURNASDAQ·USD·Closed

$1.60

+1.91%

$1.60

+$0.03 (1.91%)

52W Range

2thpctl

Volume

0.04×avg

Mkt Cap

10.20MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.04×avg

Market Cap

10.20MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings